Texas A&M Identifies Protein Improving Strangles Detection

Researchers say the P92 protein more accurately detects antibodies against the bacterium that causes strangles in horses.

Updated on Nov. 13, 2026 in Pets

Clear unlabeled sample tubes in a rack on a steel laboratory bench, with a glass microscope slide catching window light.
Texas A&M researchers identified a protein, P92, that more accurately detects antibodies against the bacterium behind strangles in horses than the existing test. AI Illustration. Upload story photo >

Researchers at the Texas A&M College of Veterinary Medicine and Biomedical Sciences identified a protein, P92, that can detect antibodies against Streptococcus equi subspecies equi, the bacterium behind strangles, one of the most common infectious diseases in horses worldwide. In comparisons, the P92 serological test was found to be more accurate than the existing SeM-based test.

Why it matters

The current SeM-based serological test can return false-positive results due to exposure to Streptococcus equi subspecies zooepidemicus and false-negative results due to SeM protein mutations in some strains. A more accurate test could help horse owners and veterinarians better determine whether a horse has strangles.

The study compared strains of SEE and SEZ collected from Texas horses and used a microarray developed with the University of California, Irvine to test candidate proteins. Researchers have not yet established P92's accuracy across wider horse populations.

The players

Texas A&M College of Veterinary Medicine and Biomedical Sciences

The College of Veterinary Medicine and Biomedical Sciences at Texas A&M University in College Station, Texas, is a major veterinary research and teaching institution.

Southwest Veterinary Diagnostics

Southwest Veterinary Diagnostics is a veterinary diagnostics company that licensed the P92 technology and is developing a rapid lateral-flow test.

Baylor College of Medicine

Baylor College of Medicine is a private medical school in Houston, Texas, known for biomedical research and clinical training.

The details

Researchers compared SEE and SEZ strains from Texas horses to find genetic differences, then worked with a University of California, Irvine laboratory to build a microarray testing how antibodies from three groups of horses responded to each candidate protein. The team licensed the technology to Southwest Veterinary Diagnostics, which is developing a rapid lateral-flow test designed to detect P92.

Timeline

  1. The article reporting the P92 study was published on November 13, 2026.

  2. Strangles has affected horses in the research team's experience for about 15 years, since Noah Cohen's daughter's horse developed the disease.

Health Landscape

The P92 study builds on the long-used SeM-based serological test, whose false-positive and false-negative limitations have shaped efforts to improve equine infectious disease diagnostics. Researchers are now positioning P92 as a more accurate alternative that could reshape how strangles is detected in horses.

Horse owners who suspect strangles should continue working with their veterinarian, since the P92 test is still in research and a rapid lateral-flow version is not yet available. Existing diagnostic methods remain the standard until more testing confirms P92's accuracy.

The takeaway

Accurate diagnosis is central to managing strangles, which spreads readily among horses, so improved antibody tests could help owners and veterinarians act sooner. Keep an eye on whether the P92 findings hold up in larger and more diverse horse populations.

Further reading

For more on animal health research, explore Veterinary Medicine coverage across Texas.

Source note: This article includes information reported by The Horse.